We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Flexible Ultrasound Patch Monitors Cardiovascular Function

By HospiMedica International staff writers
Posted on 12 Aug 2021
A novel wearable skin patch that incorporates an array of ultrasonic transducers can provide continuous monitoring of deep-tissue hemodynamics, claims a new study.

Developed at the University of California, San Diego (UCSD; USA), Yonsei University (Seoul, South Korea), the Korea Institute of Science and Technology (KIST; Seoul, Republic of Korea), and other institutions, the patch is made of a flexible, stretchable polymer that that is embedded with a 12X12 grid of millimeter-sized ultrasound transducers, in a phased array design. More...
When electricity flows through the transducers, they emit ultrasound waves that travel through the skin and deep into the body.

The computerized phased array design has two main modes of operation. In one, the transducers are synchronized to transmit ultrasound waves together, producing a high-intensity ultrasound beam that focuses on one spot up to 14 centimeters in the body. In the other mode, the transducers can be programmed to transmit out of sync, allowing for active focusing and steering of ultrasound beams over a range of incident angles so as to target various regions of interest. When the waves penetrate through a major blood vessel, they encounter movement from red blood cells (RBCs) flowing inside.

These movement changes or shifts, known as Doppler frequency shift, reflect back to the patch, and are used to create a visual recording of the blood flow. This same mechanism can also be used to create moving images of the heart’s walls. In a study conducted in healthy volunteers, the phased array patch monitored Doppler spectra from cardiac tissues, recorded central blood flow waveforms, and estimated cerebral blood supply in real time. The study was published on July 16, 2021, in Nature Biomedical Engineering.

“Sensing signals at such depths is extremely challenging for wearable electronics. Yet, this is where the body’s most critical signals and the central organs are buried,” said co-first author nanoengineer Chonghe Wang, PhD, of UCSD. “We engineered a wearable device that can penetrate such deep tissue depths and sense those vital signals far beneath the skin. This technology can provide new insights for the field of healthcare.”

Related Links:

University of California
Yonsei University
Korea Institute of Science and Technology

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.